Skip Navigation LinksHome > Collections > FDA News

FDA News

Creator:   Editor
Created:   7/14/2014
Contains:  131 items
Actions, updates, and special reports from the U.S. Food and Drug Administration about oncology-related drugs.

Show
Previous of 7 Next

Orphan Drug Status to Melphalan for Cholangiocarcinoma

Free Access
PDF
+ Favorites
Request Permissions

Orphan Drug Designation to Anisina for Neuroblastoma

Free Access
PDF
+ Favorites
Request Permissions

FDA Approves Iressa for NSCLC, along with Companion Diagnostic

Free Access
PDF
+ Favorites
Request Permissions

Priority Review for MM-398 for Metastatic Pancreatic Cancer

Free Access
PDF
+ Favorites
Request Permissions

FDA Approves Promacta for Children with Chronic ITP

Free Access
PDF
+ Favorites
Request Permissions

FDA's Priority Review to Glioblastoma Therapy for Second Indication

Free Access
PDF
+ Favorites
Request Permissions

FDA's Breakthrough Designation to Venetoclax for CLL

Free Access
PDF
+ Favorites
Request Permissions

FDA Actions for Keytruda for NSCLC and GMI-1271 for AML

Free Access
PDF
+ Favorites
Request Permissions

FDA Approves Metastatic Colorectal Cancer KRAS Mutation Test

Free Access
PDF
+ Favorites
Request Permissions

FDA Gives Fast Track Designations to Drugs for AML, Pancreatic Cancer, NSCLC, and Prevention of Oral Mucositis

Free Access
PDF
+ Favorites
Request Permissions

Orphan Drug Designation to Cantrixil for Ovarian Cancer and Selumetinib for Uveal Melanoma

Free Access
PDF
+ Favorites
Request Permissions

Priority Review to Post-Transplant Consolidation Treatment for Hodgkin Lymphoma

Free Access
PDF
+ Favorites
Request Permissions

Xalkori Gets FDA Breakthrough Therapy Designation for NSCLC Indication

Free Access
PDF
+ Favorites
Request Permissions

Two FDA Advisory Committees Recommend Approval of Talimogene for Metastatic Melanoma

Free Access
PDF
+ Favorites
Request Permissions

Cometriq (Cabozantinib) Granted Fast Track Designation for Advanced RCC

Free Access
PDF
+ Favorites
Request Permissions

Rucaparib Gets FDA Breakthrough Therapy Status for Ovarian Cancer

Free Access
PDF
+ Favorites
Request Permissions

Orphan Drug Status Given to IMO-8400 for Diffuse Large B-Cell Lymphoma

Free Access
PDF
+ Favorites
Request Permissions

FDA Approval for Label Update for Zytiga; Orphan Drug Status for Reolysin and CRS-07

Free Access
PDF
+ Favorites
Request Permissions

FDA Approves New Oral Formulation of Deferasirox (Jadenu) for Chronic Iron Overload

Free Access
PDF
+ Favorites
Request Permissions

FDA Grants Priority Review to Kyprolis for Multiple Myeloma

Free Access
PDF
+ Favorites
Request Permissions
Show
Previous of 7 Next
Collection Alerts

Stay up-to-date! Be notified every time a new item is added. Receive an Email or subscribe to an RSS feed.